In your state
Virginia

In the development of new medicines, clinical trials are conducted to prove therapeutic safety and effectiveness and compile the evidence needed for the Food and Drug Administration (FDA) to approve treatments. And the biopharmaceutical sector is committed to bringing new treatments and cures to patients. This commitment to innovation supports high-quality jobs and is a vital part of every state’s economy and our global economic competitiveness.

Economic Impact In Your State: Virginia

$12B

Total output supported by biophamaceutical sector

$508,684

Total output supported by biophamaceutical sector

47,495

Total Jobs

10,137

Direct Jobs

Clinical Trials in Your State: Virginia

759

TOTAL CLINICAL TRIALS

$267.2 million

INVESTED IN CLINICAL TRIALS

17,685

TOTAL ECONOMIC IMPACT OF CLINICAL TRIAL INVESTMENTS

$695.7 million

INVESTED IN CLINICAL TRIALS

Programs and Initiatives in Your State: Virginia

State programs and initiatives to promote biopharmaceutical industry development

    ACCELERATING INNOVATION, COMMERCIALIZATION & ENTREPRENEURIAL DEVELOPMENT

    BUILDING RESEARCH CAPACITY AND/OR R&D INFRASTRUCTURE

    ECONOMIC INNOVATION INCENTIVES

    STEM EDUCATION & WORKFORCE DEVELOPMENT

    TARGETED STRATEGIES

    VENTURE FINANCING

State Innovation Indicators

6

Patents per 1,000 people in Science & Engineering

12.4%

Percentage of Workforce Employed in High-Tech Jobs